The investigation conducted by A. Puccini et al. suggests a strong relationship between DNMT3A rs2276598 and tumor response to treatment, which was defined as the percentage of patients achieving either complete or partial remission according to the Response Evaluation Criteria in Solid Tumors classification [16]. This evidence concerns the gene DNMT3A and neoplasm.